Clinical trial
18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma
NCT03541720 is registered in ClinicalTrials.gov with St. Jude Children's Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma
- Lead sponsor
- St. Jude Children's Research Hospital
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- April 30, 2019
- Completion date
- July 1, 2028
- Enrollment
- 13 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.